0001950047-24-001996.txt : 20240307 0001950047-24-001996.hdr.sgml : 20240307 20240307161008 ACCESSION NUMBER: 0001950047-24-001996 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240307 DATE AS OF CHANGE: 20240307 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Ultragenyx Pharmaceutical Inc. CENTRAL INDEX KEY: 0001515673 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 272546083 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36276 FILM NUMBER: 24730165 BUSINESS ADDRESS: STREET 1: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 415-483-8800 MAIL ADDRESS: STREET 1: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Fust Matthew K CENTRAL INDEX KEY: 0001397266 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC. STREET 2: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 144 1 primary_doc.xml 144 0001397266 XXXXXXXX LIVE 0001515673 ULTRAGENYX PHARMACEUTICAL INC. 001-36276 60 Leveroni Court Novato CA 94949 (415) 483-8800 MATTHEW K FUST Director Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

12195 620439.32 82335687 03/07/2024 NASDAQ COMMON 06/24/2021 Restricted Stock ISSUER N 2550 06/24/2021 Not Applicable COMMON 06/24/2022 Restricted Stock ISSUER N 2145 06/24/2022 Not Applicable COMMON 03/04/2022 Exercised Shares ISSUER N 7500 03/04/2022 Not Applicable Y 03/07/2024 12/07/2023 /s/ Matthew Kyrt Fust